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Fig 2. Suturing of the pericardial patch to the semilunar lines 
of the leaflet attachments with continuous 4-0 Prolene suture 
and reinforcing of the commissural zones with Dacron pled-
gets from outside. 
ence, which is 20% more, as mentioned earlier (Fig 1, B). 
Indeed, the length of each cusp has to be equal to its projection 
into the inlet (annular) circumference to be able to straighten 
during systole when the change from the conical form to the 
cylindrical one occurs. The tilting of the cusps toward the aor-
tic wall with more complete opening of the valve becomes pos-
sible because the inlet diameter at the anulus decreases. 
Changing the cy lindrical form of the root to a conical one in 
diastole will make coaptation of the cusps possible. 
The coronary cusps are fashioned similarly and marked on 
pericardium. The pericardial patch is tailored along the 
marked line, leaving 2 to 3 mm of the tissue for the sutures 
(Fig I, B). 
The next step is removing the native valve and suturing the 
pericardial patch to the semilunar lines of the leaflet attach-
mehts (anatomic anulus) with continuous 4-0 polypropylene 
suture (Prolene; Ethicon, Inc, Somerville, NJ), which is passed 
out through the aortic wall in the commissural zones and rein-
forced with Dacron pledgets from the outside (Fig 2). Then we 
place additional mattress sutures in the commissural zones, 
passing them out through the aortic wall and the same pledgets. 
To check valve competence after reconstruction in the 
cadaver heart, we put a purse-string suture through the aortic 
wall along its circumference and subject this to hydrostatic 
pre~sure. After incising the left ventricular apex and opening 
the ventricle, we could observe the newly created aortic valve 
frob below. Complete coaptation of the leaflets with no regur-
gitant jet and competent suture lines along the leaflets attach-
ment were observed in all 5 cases. We also could observe 
gqod filling of all coronary arteries. 
We concluded that our technique of aortic valve reconstruc-
tion with an autologous pericardial patch should be tested in 
animal experiments and then possibly be tried in a clinical 
application in the future as an alternative to mechanical or 
prosthetic biologic valve implantation and/or as an intermedi-
ary procedure in young patients, postponing prosthetic valve 
replacement. 
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The prerequisite to our method is the absence of significant 
distortion of aortic root geometry in hearts with severely dis-
eased valves. 
We wish to pursue this study further and look forward to 
collaborating with others in this endeavor. 
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A stable model of chronic bilateral ventricular insuf-
ficiency (dilated cardiomyopathy) induced by arterio-
venous anastomosis and doxorubicin administration 
in sheep 
To the Editor 
Congratulations to Toyoda, Okada, and Kashem I on their 
recent article, "A Canine Model of Dilated Cardiomyopathy 
Induced by Repetitive Intracoronary Doxorubicin Adminis-
tration." We need such a simple and reproducible animal 
model of stable, nonreversible chronic heart failure if we are 
to evaluate new surgical treatments for pre-end-stage conges-
tive heart failure. The authors described cannulation of the 
coronary artery via the femoral artery and transcatheter infu-
sion of doxorubicin, which resulted in visible signs of left 
ventricular insufficiency after 5 weekly doses of intracoronary 
doxorubicin; however, they reported that "the right ventricle 
seemed to be affected only slightly by doxorubicin." 
Especially for cardiomyopathy research, one needs to create a 
model of bilateral heart failure. 
In a recently completed (unpublished) investigation involv-
ing adult sheep, we created a bilateral model through first 
inducing right ventricular insufficiency by a surgical anasto-
mosis between the right jugular vein and right external cardiac 
artery. After 1 month, we observed initial signs of insufficien-
cy in the right ventricle (Table I) but not in the left. At this 
point, we began daily administration of (intravenous, not 
intracoronary) doxorubicin, which continued for the next 4 
weeks and resulted in left ventricular insufficiency (Table II). 
Please note that we made no attempt to determine whether 
the anastomosis or doxorubicin had the greater effect in in-
ducing right ventricular insufficiency, although Toyoda, 
Okada, and Kashem observed that 5 weekly doses of the drug 
were insufficient for the purpose. On the other hand, Smink 
and colleagues2 induced quite stable bilateral ventricular insuf-
ficiency after an anastomosis was in place for only 3 months. 
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Table I. Right ventricular hemodynamic results after creation of an arteriovenous anastomosis and administration 
of intravenous doxorubicin 
RVP(mmHg) PAP (mm Hg) PCWP(mmHg) RAP (mmHg) 
Baseline 
One month after anastomosis 
One month after doxorubicin or 2 months after anastomosis 
25 ± 3 
32 ± 2* 
46 ± 2*t 
22 ±2 
28 ± 2* 
46 ± 5*t 
9±2 
14± I 
19 ± 3 
6±1 
17 ± 3* 
26 ± 4*t 
PAp, Pulmonary arterial pressure; pewp, pulmonary capillary wedge pressure; RAP, right atrial pressure; RVp, right ventricular pressure. 
*p < .05 versus baseline. 
t P < .05 versus results at I month. 
Table II. Left ventricular hemodynamic results after creation of an arteriovenous anastomosis and administration 
of intravenous doxorubicin 
ABP-S ABP-D LVP-S LVP-D HR CI LVEF 
(mmHg) (mmHg) (mmHg) (mmHg) (beats/min) (Uminlm2) (%) 
Baseline 105±9 63 ± 8 105±9 9±4 112±3 3.8 ± 0.3 77±5 
One month after anastomosis 104± 10 56±5 104± !O II ±3 123 ± 5* 3.8 ±0.2 66±4 
One month after doxorubicin 86 ± 5*t 54±4 86± 5*t 20± 2*t 142 ±3*t 2.6 ± O.3*t 43 ± 6*t 
or 2 months after anastomosis 
ABP-S, Aortic blood pressure-systole; ABP-D, aortic blood pressure----<liastole; C/, cardiac index; HR, heart rate; LVEF, left ventricular ejection fraction; qP-s, 
left ventricular pressure-systole; LVP-D, left ventricular pressure----<liastole. 
* P < .05 versus baseline. 
tP < .05 versus results at I month. 
The combined evidence of these investigations points 
toward the necessity of using both an arteriovenous anasto-
mosis and doxorubicin for a stable model of bilateral chronic 
heart failure. A model of bilateral heart failure can be espe-
cially useful for comparing surgical methods of treating 
pre-end-stage congestive heart failure, that is, cardiomyoplas-
ty, partial ventriculectomy, or implantation of artificial ven-
tricular assist devices. 
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High hem~tocrit value is a risk factor for myocardial 
infarction 
To the Editor: 
I read with interest the article on the positive correlation 
between the hematocrit value and the frequency of myocardial 
infarction (MI) after coronary artery bypass grafting (CABG) 
by Spiess and associates. l That a high hematocrit value was 
associated with an increased risk for MI has been known since 
the early 1960s.2-6 George Burch, who wrote numerous arti-
cles on this subject,z-6 advocated bloodletting in patients with 
coronary artery disease with a high hematocrit value'? He 
showed that the clinical state of these patients definitely 
improved when their hematocrit was reduced to "average nor-
mal" levels.6-s 
Burch8 wondered why bloodletting was rarely used as a 
therapeutic measure for these patients. It might be appropriate 
to quote what Burch said in 1979: 
It is well known that a high hematocrit is associated 
with high viscosity and that a highly viscous fluid re-
quires more work of the pump to circulate it than does a 
less viscous liquid. Furthermore, the flow of highly vis-
cous fluid is reduced, even with all else being equal. 
Nevertheless, physicians fail to bleed patients with active 
coronary disease and myocardial ischemia, whose hema-
tocrit is high and whose blood viscosity is increased. It 
has been shown that bloodletting in patients with 
ischemic heart disease definitely improved the clinical 
state of these patients when their hematocrit was reduced 
to average normal levels .... 
Could it be that the procedure is rarely used because it 
appears to be "old-fashioned," "antique," and not "mod-
ern"? If the concept is good and the clinical results often 
dramatic, why not use it? Just because "bloodletting" is 
a procedure of the old days and one that was misused, 
this does not justify not using it today. 
Some old things are good. Antiques are desirable and 
appreciated and antiquities are even more precious and 
